Concepedia

Arjen Q. Bakker

AQ

Statistics

Publications

41

Citations

5.1K

H-Index

30

Active since

1993

Affiliations

AIMM Therapeutics (Netherlands)(Current)

Amsterdam UMC Location University of Amsterdam

University of Amsterdam

The Netherlands Cancer Institute

Johnson & Johnson (Netherlands)

Arjen Q. Bakker is an author at AIMM Therapeutics (Netherlands) specializing in life sciences, immunology, and monoclonal antibodies.

Publications per year

1993–2020

41

Publications

41

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Jason S. McLellan, Man Chen, Michael Joyce et al. · Science · 2013 · 1.1K citations · Full text

, , +17

Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants

Jan ter Meulen, Edward N. van den Brink, Leo L. M. Poon et al. · PLoS Medicine · 2006 · 745 citations · Full text

, , +17

Id2 and Id3 Inhibit Development of Cd34+ Stem Cells into Predendritic Cell (Pre-Dc)2 but Not into Pre-Dc1

Hergen Spits, Franka Couwenberg, Arjen Q. Bakker et al. · The Journal of Experimental Medicine · 2000 · 319 citations · Full text

, , +17

Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming

Mark J. Kwakkenbos, Sean A. Diehl, Etsuko Yasuda et al. · Nature Medicine · 2009 · 302 citations · Full text

, , +14

Inhibition of T Cell and Promotion of Natural Killer Cell Development by the Dominant Negative Helix Loop Helix Factor Id3

Mirjam H.M. Heemskerk, Bianca Blom, Garry P. Nolan et al. · The Journal of Experimental Medicine · 1997 · 270 citations

, , +17

1–5 of 41